GlassScriptPhysician profile
Jamie S Lee
NPI 1215341771
$1,321.83
in general payments reported to CMS, 2019-2025
14 companies · $24.84 in 2025
The $24.84 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $118 · 2021: $281 · 2022: $229 · 2023: $53.29 · 2024: $167 · 2025: $24.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $270.53 | 2019-2022 | |
| Coopervision INC. | $183.92 | 2019-2024 | Paragon Crt, Myday Contact Lens |
| Shire North American Group INC | $152.32 | 2019 | |
| Aerie Pharmaceuticals, INC. | $94.95 | 2019-2021 | |
| Dompe US, INC. | $93.03 | 2024 | Oxervate |
| Novartis Pharmaceuticals Corporation | $89.58 | 2019-2021 | |
| Alcon Vision LLC | $73.83 | 2021-2024 | Dailies Total1 |
| Sun Pharmaceutical Industries INC. | $67.48 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $61.76 | 2021 | |
| Oyster Point Pharma, INC. | $55.02 | 2022-2023 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $50.84 | 2019-2020 | |
| Abbvie INC. | $46.46 | 2022 | |
| Allergan, INC. | $41.63 | 2020-2021 | |
| Abb Con-Cise Optical Group LLC | $40.48 | 2019-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.